Autoimmunity in Graves' Ophthalmopathy: A Review

Lewis M , Topliss DJ , Okita N , How J , Row VV , Volpé R. The etiology of endocrine exophthalmos. In: Franklin EC , ed. Clinical immunology update. New York: Elsevier Biomedical, 1983: 261–80

Jacobson DH , Gorman CA . Endocrine ophthalmopathy: Current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 1984; 5: 200–20

Pope RM , Ludgate ME , McGregor AM . Observations on Graves' ophthalmopathy: Pathology and pathogenesis. In: McGregor AM , ed. Immunology of endocrine diseases. Lancaster: MTP Press, 1986: 161–80

Amino N , Yuasa T , Yabu Y , Miyai K. Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab 1980; 51: 1232–4

Werner SC , Coleman DJ , Franzen LA . Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. N Engl J Med 1974; 308: 420–4

Enzmann DR , Donaldson SS , Kriss JP . Appearance of Graves' eye disease on orbital computed tomography. J Comput Assist Tomogr 1979; 3: 815–9

Mauri L , Meienberg O , Roth E , Konig MP . Evaluation of endocrine opthalmopathy with saccadic eye movements. J Neurol 1984; 231: 182–7

Gamblin GT , Harper DG , Galentine P , Buck DR , Chernow B , Eil C. Prevalence of increased intraocular pressure in Graves' disease – evidence of frequent subclinical ophthalmopathy. N Engl J Med 1983; 308: 420–4

Allen C , Stetz D , Roman SH , Podos S , Som P , Davies TF . Prevalence and clinical associations of intraocular pressure changes in Graves' disease. J Clin Endocrinol Metab 1985; 61: 183–7

Teng CSS , Yeo PPB . Ophthalmic Graves' disease: Natural history and detailed thyroid function studies. Br Med J 1977; 1: 273–5

Gwinup G , Elias AN , Ascher MS . Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 1982; 247: 2135–8

Weetman AP , McGregor AM . Autoimmune thyroid disease – developments in our understanding. Endocr Rev 1984; 5: 309–55

Hagg E , Asplimol K. Is endocrine ophthalmology related to smoking? Br Med J 1987; 295: 634–5

Teng CS , Smith BR , Clayton B , Evered DC , Clark F , Hall R. Thyroid stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol 1977; 6: 207–11

Trokel SL , Jakobiec FA . Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology 1981; 88: 553–64

Campbell RJ . Pathology of Graves' ophthalmopathy. In: Gorman CA , Waller RA , Dyer JA , eds. The eye and orbit in thyroid disease. New York: Raven Press 1984: 25–31

Daicker B. Das gewebliche Substrat der Verdickten ausseren Augenmuskeln bei der endokrinen Orbitopathie. Klin Monatsbl Augenheilkd 1979; 174: 843–7

Sisson JC , Vanderburg JA . Lymphocyte-retrobulbar fibroblast interaction: Mechanisms by which stimulation occurs and inhibition of stimulation. Invest Ophthalmol 1972; 11: 15–20

Roberts AB , Anzano MA , Wakefield LM , Roche NS , Stern DF , Sporn MB . Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 1985; 82: 119–23

Ramsay ID . Muscle dysfunction in hyperthyroidism. Lancet 1966; ii: 931–5

Mahieu P , Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab 1972; 34: 1090–2

Munro RE , Lamki L , Row VV , Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab 1973; 37: 286–92

Volpé R , Row VV . Proportion of E rosettes normal in Graves' and Hashimoto's diseases: A retraction (letter). N Engl J Med 1975; 293: 44

Mullin BR , Levinson RE , Friedman A , Henson DE , Winand RJ , Kohn LD . Delayed hypersensitivity in Graves' disease and exophthalmos: Identification of thyroglobulin in normal human orbital muscle. Endocrinology 1977; 100: 351–66

Kriss JP . Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab 1970; 40: 872–5

Konishi J , Herman MN , Kriss JP . Binding of thyroglobulin and thyroglobulin – antithyroglobulin complex to extraocular muscle membrane. Endocrinology 1974; 95: 434–66

Wall JR , Trewin A , Fang SL , Ingbar SH , Braverman LE . Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease, J Endocrinol Invest 1978; 1: 253–8

Wall JR , Strakosch CR , Fang SL , Ingbar SH , Braverman LE . Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: Effect of treatment with cyclophosphamide. Clin Endocrinol 1979; 10: 79–91

Wall JR , Walters BAJ , Grant C. Leukocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest 1979; 2: 375–8

Wall JR . Role of cellular mechanisms in the orbital autoimmunity of Graves' ophthalmopathy. J Endocrinol Invest 1986; 9 (Suppl 3): 71(abstract)

Blau HM , Kaplan I , Tao TW , Kriss JP . Thyroglobulin-independent cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' disease. Life Sci 1983; 32: 45–53

Wang PW , Hiromatsu Y , Laryea E , Wosu L , How J , Wall JR . Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. J Clin Endocrinol Metab 1986: 63:316–22

Hiromatsu Y , Fukazawa H , How J , Wall JR . Antibody-dependent cell-mediated cytoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy – roles of class IIMHC antigen expression and 7-interferon action on effector and target cells. Clin Exp Immunol 1987; 70: 593–603

Henderson J , Wall JR . Failure of haemagglutination and immunofluorescence methods to detect serum orbital antibodies in patients with Graves' ophthalmopathy. Clin Endocrinol 1987; 14: 153–8

Mengistu M , Laryea E , Miller A , Wall JR . Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence. Clin Exp Immunol 1986; 65: 19–27

Kodama K , Sikorska H , Bandy-Dafoe P , Bayly R , Wall JR . Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet 1982; ii: 1353–6

Kendall-Taylor P , Atkinson S , Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J 1984; 288: 1183–6

Atkinson S , Holcombe M , Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet 1984; ii: 374–6

Farnya M , Nauman J , Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy. Br Med J 1985; 290: 191–3

Sikorska H , Wall JR . Failure to detect eye muscle membrane specific autoantibodies in Graves' ophthalmopathy. Br Med J 1985; 291: 604(letter)

Kadlubowski M , Irvine WJ , Rowland AC . The lack of specificity of ophthalmic immunoglobulins in Graves' disease. J Clin Endocrinol Metab 1986; 63: 990–5

Ahmann A , Baker JR , Weetman AP , Wartofsky L , Nutman TB , Burman KD . Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy; identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1987; 64: 454–60

Kadlubowski M , Irvine WJ , Rowland AC . Anti-muscle antibodies in Graves' ophthalmopathy. J Clin Lab Immunol 1987; 24: 105–11

Rousset B , Bernier-Valentin F , Poncet C . Antitubulin antibodies in autoimmune thyroid disorders. Clin Exp Immunol 1983; 52: 3325–32

Kendall-Taylor P , Jones D , Atkinson S. The specificity of autoantibodies in Graves' ophthalmopathy. Acta Endocrinol 1987; Suppl 281:330–3

Kodama K , Sikorska H , Bayly R , Bandy-Dafoe P , Wall JR . Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy. J Clin Endocrinol Metab 1984; 59: 67–73

Kuroki T , Ruf J , Whelan L , Miller A , Wall JR . Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: A possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin Exp Immunol 1985; 62: 361–70

Tao TW , Cheng PJ , Pham H , Leu SL , Kriss JP . Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab 1986; 63: 577–82

Schumacher M , Camp S , Manlet Y . Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature 1986; 319: 407–9

Ludgate M , Swillens S , Mercken L , Vassart G. Homology between thyroglobulin and, acetylcholinesterase: An explanation for pathogenesis of Graves' ophthalmopathy. Lancet 1986; ii: 219(letter)

Ludgate M , Owada C , Pope R , Taylor P , Vassart G. Cross reactivity between antibodies to human thyrogobulin (HTg) and Torpedo acetylcholinesterase (TAChE) in patients with Graves' ophthalmopathy (GO). J Endocrinol Invest 1986; 9: (suppl 3),89(abstract)

Soreq H , Dreyfus P , Zisling R , Zamir R , Zakut H , Ludgate M. Antibodies to cholinesterase in the serum of Graves' ophthalmopathy patients. Ann Endocrinol 1987; 48: 131(abstract)

Weetman AP , Tse CK , Randall WR , Tsim KWK , Barnard EA . Acetylcholineasterase antibodies and thyroid autoimmunity. Clin Exp Immunol 1988; 71: 96–9

Rotella CM , Zonefrati R , Toccafondi R , Valente WA , Kohn LD . Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: An assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 1986; 62: 357–67

Bahn RS , Gorman CA , Woloschak GE , David CS , Johnson PM , Johnson CM . Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab 1987; 65: 665–70

Farid NR , Stone E , Johnson G. Graves' disease and HLA: Clinical and epidemiologic associations. Clin Endocrinol 1980; 13: 535–44

Schleusener H , Schernthaner G , Mayr WR . HLA-DR3 and HLA-DR5 associated thyrotoxicosis – two different types of toxic diffuse goitre. J Clin Endocrinol Metab 1983; 56: 781–5

Frecker M , Stenszky V , Bálázs C , Kozma L , Kraszits E , Farid NR . Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 1986; 25: 479–85

Kendall-Taylor P , Duggan-Keen M , Stephenson AM , Stratton A , Roberts D. Genetic markers in Graves' ophthalmopathy. J Endocrinol 1987; 112 (supplement): abstract 138

Bech K , Lumholtz B , Nerup J. . HLA antigens in Graves' disease. Acta Endocrinol 1977; 86: 510–6

Allanic H , Fauchet R , Lorcy Y . HLA and Graves' disease; an association with HLA-DRW3. J Clin Endocrinol Metab 1980; 51: 863–7

Weetman AP , So AK , Warner CA , Foroni L , Fells P , Shine B. Immunogenetic markers in Graves' ophthalmopathy. Clin Endocrinol 1988; 28: 619–28

Sridma V , Hara Y , Fauchet R , De Groot LJ . HLA immunogenetic heterogeneity in black American patients with Graves' disease. Arch Intern Med 1987; 147: 229–31

Sergott RC , Felberg NT , Savino PJ , Blizzard JT , Schatz NJ , Sanford CA . Association of HLA antigen BW35 with severe Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 1983; 24: 124–12

Nakao Y , Matsumoto H , Miyazaki T . IgG heavy chain allotypes (Gm) in autoimmune diseases. Clin Exp Immunol 1980; 42: 20–6

Adams DD , Adams YJ , Knight JG . On the nature of the genes influencing the prevalence of Graves' disease. Life Sci 1983; 32: 3–14